COVID-19 vaccine is safe for children ages 3 to 17 years of age
- Sinovac said its COVID-19 vaccine is safe for children ages 3 to 17 years of age, based on preliminary data, and it has submitted the data to Chinese drug regulators.
- More than 70 million shots of Sinovac’s vaccine have been given worldwide also including in China.
- China has approved in adults but it has not yet been used in children, because their immune systems may respond differently to the vaccine.
- Early and mid-stage clinical trials with over 550 subjects showed the vaccine would induce an immune response, Gang Zeng, the medical director at Sinovac, said at a news conference Monday.
- Two recipients developed high fevers in response to the vaccine, one a 3-year-old and the other a 6-year-old. The rest of the trial subjects experienced mild symptoms, Zeng said.
- Children are far less likely to be seriously ill with COVID-19, but they are still at risk and can spread the virus. And while vaccination campaigns worldwide have focused on adults, children will need to be immunized to end the pandemic.